Hypercalcemia Associated with Cancer
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
A 47-year-old woman with a history of breast cancer presents with confusion and dehydration. The serum calcium level is 18.0 mg per deciliter. She has postural hypotension and low central venous pressure. The serum phosphorus level is 5.0 mg per deciliter, the blood urea nitrogen level 80 mg per deciliter, the serum creatinine level 2.0 mg per deciliter, and the albumin level 3.3 g per deciliter. Bone scintigraphy reveals no evidence of skeletal involvement by the tumor. How should she be treated?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
Hillner, B. E., Ingle, J. N., Chlebowski, R. T., Gralow, J., Yee, G. C., Janjan, N. A., Cauley, J. A., Blumenstein, B. A., Albain, K. S., Lipton, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.017 · Cited by 970
Major, P., Lortholary, A., Hon, J., Abdi, E., Mills, G., Menssen, H. D., Yunus, F., Bell, R., Body, J., Quebe-Fehling, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.558 · Cited by 858
Guise, T. A., Yin, J. J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., & Mundy, G. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118947 · Cited by 851
Bekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040305 · Cited by 771
The effect of a single dose of osteoprotegerin in postmenopausal women.
Bekker, P. J., Holloway, D., Nakanishi, A., Arrighi, M., Leese, P. T., & Dunstan, C. R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.2.348 · Cited by 484
Toxic acute tubular necrosis following treatment with zoledronate (Zometa)
Markowitz, G. S., Fine, P. L., Stack, J. I., Kunis, C. L., Radhakrishnan, J., Palecki, W., Park, J., Nasr, S. H., Hoh, S., Siegel, D. S., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00071.x · Cited by 384
Asymptomatic Primary Hyperparathyroidism
Bilezikian, J. P., & Silverberg, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp032200 · Cited by 377
STEWART, A. F., VIGNERY, A., SILVERGLATE, A., RAVIN, N. D., LiVOLSI, V., BROADUS, A. E., & BARON, R. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-2-219 · Cited by 287
Self-citationInorganic Phosphate Treatment of Hypercalcemia of Diverse Etiologies
Goldsmith, R. S., & Ingbar, S. H. (1966) · New England Journal of Medicine · doi:10.1056/nejm196601062740101 · Cited by 246
Nussbaum, S. R., Younger, J., Vandepol, C. J., Gagel, R. F., Zubler, M. A., Chapman, R., Henderson, I. C., & Mallette, L. E. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90282-t · Cited by 228
Treatment of Severe Hypophosphatemia
Lentz, R. D., BROWN, D. M., & KJELLSTRAND, C. M. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-6-941 · Cited by 215
Effect of Calcitonin and Glucocorticoids in Combination on the Hypercalcemia of Malignancy
BINSTOCK, M. L., & MUNDY, G. R. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-2-269 · Cited by 199
Mithramycin treatment of hypercalcemia
Perlia, C. P., Nj, G., Wolter, J. M., Edelberg, D., Dederick, M. M., & Taylor, S. G. (1970) · Cancer · doi:10.1002/1097-0142(197002)25:2<389::aid-cncr2820250217>3.0.co;2-x · Cited by 172
A Dose-Finding Study of Zoledronate in Hypercalcemic Cancer Patients
Body, J. J., Lortholary, A. H., Romieu, G., Vigneron, A.-M., & Ford, J. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.9.1557 · Cited by 151
Gucalp, R. A., Ritch, P. S., Wiernik, P. H., Sarma, P. R., Keller, A. M., Richman, S. P., Tauer, K. W., Neidhart, J. A., Mallette, L. E., & Siegel, R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.134 · Cited by 150
Horwitz, M. J., Tedesco, M. B., Sereika, S. M., Hollis, B. W., Garcia-Ocaña, A., & Stewart, A. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020773 · Cited by 130
Self-citationDose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia
Ralston, S. H., Thiébaud, D., Herrmann, Z., Steinhauer, E., Thurlimann, B. J. K., Walls, J., Lichinitser, M., Rizzoll, R., Hagberg, H., Huss, H., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.48 · Cited by 129
Hypercalcemia of Malignancy: Treatment with Intravenous Dichloromethylene Diphosphonate
Jacobs, T. P., SIRIS, E. S., BILEZIKIAN, J. P., BAQUIRAN, D. C., SHANE, E., & CANFIELD, R. E. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-3-312 · Cited by 124
Comparison of two parenteral diphosphonates in hypercalcemia of malignancy
Jung, A. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90813-0 · Cited by 120
Pecherstorfer, M., Steinhauer, E. U., Rizzoli, R., Wetterwald, M., & Bergstr�m, B. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-003-0477-1 · Cited by 93
Cheer, S. M., & Noble, S. (2001) · Drugs · doi:10.2165/00003495-200161060-00010 · Cited by 78
Safety of pamidronate in patients with renal failure and hypercalcemia.
Machado, C., & Flombaum, C. D. (1996) · PubMed · Cited by 77
Phosphate depletion in the rat: Effect of bisphosphonates and the calcemic response to PTH
Jara, A., Lee, E., Stauber, D. J., Moatamed, F., Felsenfeld, A. J., & Kleeman, C. R. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00395.x · Cited by 28
Cited by
Palumbo, A., & Anderson, K. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011442 · Cited by 2,326
Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors
Bamias, A., Kastritis, E., Bamia, C., Moulopoulos, L. A., Melakopoulos, I., Bozas, G., Koutsoukou, V., Gika, D., Anagnostopoulos, A., Papadimitriou, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8670 · Cited by 1,149
Ruggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B., & Kademani, D. (2022) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2022.02.008 · Cited by 1,141
Essential metals in health and disease
Jomova, K., Makova, M., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., Rhodes, C. J., & Valko, M. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110173 · Cited by 1,121
Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment
Pelosof, L. C., & Gerber, D. E. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0099 · Cited by 773
Metadata
- Authors
- Stewart, A. F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-01-27
- Volume
- 352
- Issue
- 4
- Pages
- 373-379
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2070636400
- Cited by
- 973
- References
- 24
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.